Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Tacrolimus Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 1,200
- 试验地点
- 1
- 主要终点
- AKI
研究概览
简要总结
In this study, the investigators aim to develop a risk prediction model for acute kidney injury (AKI) in hospitalized patients using the calcineurin inhibitor tacrolimus. This will be achieved by mining electronic medical record data and employing explainable deep learning methods. The model will provide clinical decision support for timely intervention and treatment. Compared to traditional machine learning models, deep neural networks can extract more nuanced features from complex medical data and perform more precise pattern recognition, thereby enhancing prediction accuracy and reliability. By constructing a predictive tool based on explainable deep learning models, the investigators will better assess the association between the use of calcineurin inhibitors and AKI, explore targeted prevention strategies, and offer more precise predictions and intervention guidance to clinicians. Additionally, this research has significant socio-economic benefits and application potential. By reducing the incidence of AKI, the investigators can lower patient hospitalization duration and re-treatment costs, conserve medical resources, and improve patient quality of life. Preventive healthcare not only alleviates the physical and psychological burden on patients but also reduces the strain on the healthcare system, enhances healthcare efficiency, and promotes the rational allocation of medical resources.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Use of tacrolimus during hospitalization, with standardized therapeutic drug monitoring
- •Age of 18 years or older at the time of admission
- •Length of hospital stay ≥ hours
- •At least two serum creatinine level tests conducted during the hospital stay
排除标准
- •Stage 5 chronic kidney disease prior to admission
- •Incomplete clinical data
- •Serum creatinine levels consistently below 40 mmol/L during hospitalization
结局指标
主要结局
AKI
时间窗: From January 2020 to December 2023
Acute kidney injury occurred after the patient took tacrolimus during hospitalization
次要结局
未报告次要终点
研究者
Xiao Li,MD
Associate professor of pharmacy
Qianfoshan Hospital
